UK, France, Germany and Italy said in a joint statement they are prepared to lift related sanctions on Iran if the US and Iran reach an agreement to end the war, in exchange for Iran taking measures on its nuclear program.

Baili Tianheng (02615.HK) said its in-house bispecific ADC iza-bren (BL-B01D1) has had a marketing application for triple-negative breast cancer accepted by the National Medical Products Administration’s Center for Drug Evaluation. The filing covers treatment of unresectable locally advanced or metastatic TNBC in patients who progressed on prior taxane therapy. This is the drug’s third MAA acceptance by the CDE, after submissions for nasopharyngeal carcinoma and esophageal squamous cell carcinoma.

TAKAICHI said the Iran agreement reflects the parties' commitment to a diplomatic solution and is the result of sustained negotiation efforts. She praised the efforts of the countries that mediated the process.